		<rss version="2.0">
		<channel>
		<title>Pargluva News RSS Feed - Lawyer Seek Litigation</title>
		<link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Pargluva-P23/News/</link>
		<description>What is Pargluva? 
Pargluva, which has the generic name of muraglitazar, is sponsored by Bristol-Myers Squibb and Merck, and is a member of a new class of drugs known as dual PPAR-agonists. These are non-insulin drugs designed for type 2 diabetes patients in order to control their blood sugar and improve cholesterol levels by stimulating certain receptors in cells that are responsible for regulating fat and sugar. These drugs are aimed at reducing blood sugar levels while increasing levels of so called &#34;good&#34; cholesterol. Type 2 diabetes affects approximately 18 million people, and is the most widespread ... </description>
		<language>en-us</language>
		
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Pargluva-P23/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature.</description>			
			</item>			
					<item>
			<title>Accident Raises Safety Concerns About Chinese Tires</title><link>http://www.lawyerseek.com/Practice/Pharmaceutical-Injury-C1/Pargluva-P23/News/</link><description>Wall Street Journal reports that more than 450,000 Chinese-made tires may lack an important safety feature</description>			
			</item>			
				
		</channel>
		</rss> 
		